the Appropriate Use of AFIP’s Tissue Repository Following Its Transfer to the Joint Pathology Center, provides responses to those questions.
The committee organized its response to its statement of task in three primary chapters addressing the following topics:
Those chapters contain the detailed literature reviews and analysis of their relevance to the JPC biorepository that build the foundation for the committee’s findings, conclusions, and recommendations presented in Chapter 4.
Background information on the biorepository’s collection is summarized below.
As of 2011, the JPC tissue repository comprised some 7.4 million accessions that contained specimens or data from about 3.2 million people (Baker personal communication, 2011). About 3.2 million of the accessions are in the Central Collection, which is composed primarily of biologic materials submitted for consultation by military, other government, and civilian medical providers. Most of the remaining 4.2 million accessions are from military medical facilities closed under BRAC Commission proceedings. They differ from those in the Central Collection in that they include the complete array of data and specimens collected in the course of the provision of routine medical care. About two-thirds of the so-called BRAC Col-